Search research articles
Contact Us
Filters
Showing results (11-20 of 59) with videos related to
Page
of 6
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 2, 2007
Integrin-linked kinase: dispensable for radiation survival of three-dimensionally cultured fibroblasts
Stephanie Hehlgans, Iris Eke, Yvonne Deuse, et al.
Cancer Letters
|
April 19, 2015
Modulation of inflammation by low and high doses of ionizing radiation: Implications for benign and malign diseases
Benjamin Frey, Stephanie Hehlgans, Franz Rödel, et al.
Plos One
|
August 4, 2009
The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck
Iris Eke, Franziska Leonhardt, Katja Storch, et al.
International Journal of Oncology
|
February 28, 2018
Differential effects of α-catenin on the invasion and radiochemosensitivity of human colorectal cancer cells
Sarah Förster, Stephanie Hehlgans, Franz Rödel, et al.
International Journal of Radiation Biology
|
December 15, 2010
Human head and neck squamous cell carcinoma cell lines are differentially radiosensitised by the honeybee product Propolis
Stephanie Hehlgans, Inga Lange, Iris Eke, et al.
Cancer Letters
|
February 22, 2017
Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2
Amel Badawi, Stephanie Hehlgans, Josef Pfeilschifter, et al.
Radiation Research
|
July 18, 2012
The impact of cell-cell contact, E-cadherin and EGF receptor on the cellular radiosensitivity of A431 cancer cells
Ercole Mazzeo, Stephanie Hehlgans, Vincenzo Valentini, et al.
Cancers
|
February 9, 2021
Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer-A Promising Signaling Network for Therapeutic Interventions
Ömer Güllülü, Stephanie Hehlgans, Claus Rödel, et al.
Radiation Oncology (London, England)
|
September 19, 2015
The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis
Stephanie Hehlgans, Julius Oppermann, Sebastian Reichert, et al.
Expert Opinion on Drug Discovery
|
May 20, 2022
Advances in nanotechnology-based platforms for survivin-targeted drug discovery
Rosemol George, Stephanie Hehlgans, Maximillian Fleischmann, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 59) with videos related to
Sort By:
Page
of 6
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 2, 2007
Integrin-linked kinase: dispensable for radiation survival of three-dimensionally cultured fibroblasts
Stephanie Hehlgans, Iris Eke, Yvonne Deuse, et al.
Cancer Letters
|
April 19, 2015
Modulation of inflammation by low and high doses of ionizing radiation: Implications for benign and malign diseases
Benjamin Frey, Stephanie Hehlgans, Franz Rödel, et al.
Plos One
|
August 4, 2009
The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck
Iris Eke, Franziska Leonhardt, Katja Storch, et al.
International Journal of Oncology
|
February 28, 2018
Differential effects of α-catenin on the invasion and radiochemosensitivity of human colorectal cancer cells
Sarah Förster, Stephanie Hehlgans, Franz Rödel, et al.
International Journal of Radiation Biology
|
December 15, 2010
Human head and neck squamous cell carcinoma cell lines are differentially radiosensitised by the honeybee product Propolis
Stephanie Hehlgans, Inga Lange, Iris Eke, et al.
Cancer Letters
|
February 22, 2017
Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2
Amel Badawi, Stephanie Hehlgans, Josef Pfeilschifter, et al.
Radiation Research
|
July 18, 2012
The impact of cell-cell contact, E-cadherin and EGF receptor on the cellular radiosensitivity of A431 cancer cells
Ercole Mazzeo, Stephanie Hehlgans, Vincenzo Valentini, et al.
Cancers
|
February 9, 2021
Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer-A Promising Signaling Network for Therapeutic Interventions
Ömer Güllülü, Stephanie Hehlgans, Claus Rödel, et al.
Radiation Oncology (London, England)
|
September 19, 2015
The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis
Stephanie Hehlgans, Julius Oppermann, Sebastian Reichert, et al.
Expert Opinion on Drug Discovery
|
May 20, 2022
Advances in nanotechnology-based platforms for survivin-targeted drug discovery
Rosemol George, Stephanie Hehlgans, Maximillian Fleischmann, et al.
Page
of 6